Homeostatic control of brain function - New approaches to understand epileptogenesis

Frontiers in Cellular Neuroscience

Volumn , Issue JUNE, 2013, Pages

  Boison, Detlev ^a   Sandau, Ursula S ^a   Ruskin, David N ^b   Kawamura, Masahito ^c   Masino, Susan A ^b  

^a LEGACY RESEARCH   (United States)

^b TRINITY COLLEGE   (United States)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE RELEASING SILK; BIOPOLYMER; DNA METHYLTRANSFERASE INHIBITOR; PURINE NUCLEOSIDE; UNCLASSIFIED DRUG;

ASTROCYTE; BIOENERGY; BRAIN FUNCTION; BRAIN NERVE CELL; DIET THERAPY; DRUG TARGETING; ENVIRONMENTAL FACTOR; EPIGENETICS; EPILEPSY; EPILEPTOGENESIS; GENOME; HOMEOSTASIS; HUMAN; MITOCHONDRION; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NONHUMAN; REVIEW;

EID: 85172036233     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00109     Document Type: Review

References (154)

1. Alanko, L., Porkka-Heiskanen, T., and Soinila, S. (2006). Localization of equilibrative nucleoside transporters in the rat brain. J Chem Neuroanat 31, 162-268.
2. Anderson, C.M., Bergher, J.P., and Swanson, R.A. (2004). ATP-induced ATP release from astrocytes. J Neurochem 88, 246-256.
3. Arch, J.R., and Newsholme, E.A. (1978). Activities and some properties of 5'-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem J 174, 965-977.
4. Aronica, E., Ravizza, T., Zurolo, E., and Vezzani, A. (2012). Astrocyte immune responses and epilepsy. Glia 60, 1258-1268.
5. Aronica, E., Sandau, U.S., Iyer, A., and Boison, D. (2013). Glial Adenosine Kinase-a Neuropathological Marker of the Epileptic Brain. Neurochem Int in press.
6. Baborka, C.J. (1930). Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch Neurol 6, 904-914.
7. Baldwin, S.A., Beal, P.R., Yao, S.Y., King, A.E., Cass, C.E., and Young, J.D. (2004). The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447, 735-743.
8. Binder, D.K., Nagelhus, E.A., and Ottersen, O.P. (2012). Aquaporin-4 and epilepsy. Glia 60, 1203-1214.
9. Binder, D.K., Oshio, K., Ma, T., Verkman, A.S., and Manley, G.T. (2004a). Increased seizure threshold in mice lacking aquaporin-4 water channels. Neuroreport 15, 259-262.
10. Binder, D.K., Papadopoulos, M.C., Haggie, P.M., and Verkman, A.S. (2004b). In vivo measurement of brain extracellular space diffusion by cortical surface photobleaching. J Neurosci 24, 8049-8056.
11. Bjursell, M.K., Blom, H.J., Cayuela, J.A., Engvall, M.L., Lesko, N., Balasubramaniam, S., Brandberg, G., Halldin, M., Falkenberg, M., Jakobs, C., Smith, D., Struys, E., Von Dobeln, U., Gustafsson, C.M., Lundeberg, J., and Wedell, A. (2011). Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am J Hum Genet 89, 507-515.
12. Boehmler, W., Petko, J., Woll, M., Frey, C., Thisse, B., Thisse, C., Canfield, V.A., and Levenson, R. (2009). Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patterns 9, 144-151.
13. Boison, D. (2007). Adenosine as a modulator of brain activity. Drug News Persp 20, 607-611.
14. Boison, D. (2013). Adenosine kinase: exploitation for therapeutic gain. Pharmacological Reviews 65, 906-943.
15. Boison, D., Scheurer, L., Zumsteg, V., Rülicke, T., Litynski, P., Fowler, B., Brandner, S., and Mohler, H. (2002). Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci USA 99, 6985-6990.
16. Borges, K., Gearing, M., Mcdermott, D.L., Smith, A.B., Almonte, A.G., Wainer, B.H., and Dingledine, R. (2003). Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 182, 21-34.
17. Bough, K.J., Wetherington, J., Hassel, B., Pare, J.F., Gawryluk, J.W., Greene, J.G., Shaw, R., Smith, Y., Geiger, J.D., and Dingledine, R.J. (2006). Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60, 223-235.
18. Brambilla, R., Cottini, L., Fumagalli, M., Ceruti, S., and Abbracchio, M.P. (2003). Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43, 190-194.
19. Brundege, J.M., and Dunwiddie, T.V. (1996). Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J Neurosci 16, 5603-5612.
20. Butler, T., Ichise, M., Teich, A.F., Gerard, E., Osborne, J., French, J., Devinsky, O., Kuzniecky, R., Gilliam, F., Pervez, F., Provenzano, F., Goldsmith, S., Vallabhajosula, S., Stern, E., and Silbersweig, D. (2013). Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging 23, 129-131.
21. Cacheaux, L.P., Ivens, S., David, Y., Lakhter, A.J., Bar-Klein, G., Shapira, M., Heinemann, U., Friedman, A., and Kaufer, D. (2009). Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 29, 8927-8935.
22. Caiafa, P., Guastafierro, T., and Zampieri, M. (2009). Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. Faseb J 23, 672-678.
23. Carmignoto, G., and Haydon, P.G. (2012). Astrocyte Ca2+ signalling and epilepsy. Glia 60, 1227-1234.
24. Cavus, I., Kasoff, W.S., Cassaday, M.P., Jacob, R., Gueorguieva, R., Sherwin, R.S., Krystal, J.H., Spencer, D.D., and Abi-Saab, W.M. (2005). Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol 57, 226-235.
25. Chiari, A., Yaksh, T.L., Myers, R.R., Provencher, J., Moore, L., Lee, C.S., and Eisenach, J.C. (1999). Preclinical toxicity screening of intrathecal adenosine in rats and dogs. Anesthesiology 91, 824-832.
26. Clark, R.S., Carcillo, J.A., Kochanek, P.M., Obrist, W.D., Jackson, E.K., Mi, Z., Wisneiwski, S.R., Bell, M.J., and Marion, D.W. (1997). Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 41, 1284-1292; discussion 1292-1293.
27. Coco, S., Calegari, F., Pravettoni, E., Pozzi, D., Taverna, E., Rosa, P., Matteoli, M., and Verderio, C. (2003). Storage and release of ATP from astrocytes in culture. J Biol Chem 278, 1354-1362.
28. Cotrina, M.L., Lin, J.H., Alves-Rodrigues, A., Liu, S., Li, J., Azmi-Ghadimi, H., Kang, J., Naus, C.C., and Nedergaard, M. (1998). Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci U S A 95, 15735-15740.
29. Coulter, D.A., and Eid, T. (2012). Astrocytic regulation of glutamate homeostasis in epilepsy. Glia 60, 1215-1226.
30. David, Y., Cacheaux, L.P., Ivens, S., Lapilover, E., Heinemann, U., Kaufer, D., and Friedman, A. (2009). Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J Neurosci 29, 10588-10599.
31. De Sarro, G., De Sarro, A., Di Paola, E.D., and Bertorelli, R. (1999). Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 371, 137-145.
32. Delaney, S.M., and Geiger, J.D. (1996). Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. J Neurosci Meth 64, 151-156.
33. Devinsky, O., Vezzani, A., Najjar, S., De Lanerolle, N.C., and Rogawski, M.A. (2013). Glia and epilepsy: excitability and inflammation. Trends Neurosci 36, 174-184.
34. Dimauro, S., Andreu, A.L., and De Vivo, D.C. (2002). Mitochondrial disorders. J Child Neurol 17 Suppl 3, 3S35-45; discussion 33S46-37.
35. Dixon, A.K., Gubitz, A.K., Sirinathsinghji, D.J., Richardson, P.J., and Freeman, T.C. (1996). Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118, 1461-1468.
36. Dolezelova, E., Nothacker, H.P., Civelli, O., Bryant, P.J., and Zurovec, M. (2007). A Drosophila adenosine receptor activates cAMP and calcium signaling. Insect Biochem Mol Biol 37, 318-329.
37. Drane, D.L., and Meador, K.J. (2002). Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 3, 49-53.
38. During, M.J., and Spencer, D.D. (1992). Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32, 618-624.
39. Dworkin, J.P., Lazcano, A., and Miller, S.L. (2003). The roads to and from the RNA world. J Theor Biol 222, 127-134.
40. Eid, T., Lee, T.S., Thomas, M.J., Amiry-Moghaddam, M., Bjornsen, L.P., Spencer, D.D., Agre, P., Ottersen, O.P., and De Lanerolle, N.C. (2005). Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus. Proc Natl Acad Sci U S A 102, 1193-1198.
41. Eid, T., Thomas, M.J., Spencer, D.D., Runden-Pran, E., Lai, J.C., Malthankar, G.V., Kim, J.H., Danbolt, N.C., Ottersen, O.P., and De Lanerolle, N.C. (2004). Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 363, 28-37.
42. Eisenach, J.C., Hood, D.D., and Curry, R. (2002a). Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 96, 24-28.
43. Eisenach, J.C., Hood, D.D., and Curry, R. (2002b). Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 96, 29-34.
44. Etherington, L.A., Patterson, G.E., Meechan, L., Boison, D., Irving, A.J., Dale, N., and Frenguelli, B. (2009). Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology 56, 429-437.
45. Eulenburg, V., and Gomeza, J. (2010). Neurotransmitter transporters expressed in glial cells as regulators of synapse function. Brain Res Rev 63, 103-112.
46. Feil, R., and Fraga, M.F. (2011). Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 13, 97-109.
47. Feng, J., Zhou, Y., Campbell, S.L., Le, T., Li, E., Sweatt, J.D., Silva, A.J., and Fan, G. (2010). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13, 423-430.
48. Feng, Z., and Durand, D.M. (2006). Effects of potassium concentration on firing patterns of lowcalcium epileptiform activity in anesthetized rat hippocampus: inducing of persistent spike activity. Epilepsia 47, 727-736.
49. Fiebich, B.L., Biber, K., Lieb, K., Van Calker, D., Berger, M., Bauer, J., and Gebicke-Haerter, P.J. (1996). Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2areceptors. Glia 18, 152-160.
50. Fredholm, B.B., Chen, J.F., Masino, S.A., and Vaugeois, J.M. (2005). Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 45, 385-412.
51. Fredholm, B.B., Ijzerman, A.P., Jacobson, K.A., Linden, J., and Muller, C.E. (2011). International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev 63, 1-34.
52. Freeman, J.M., Vining, E.P., Kossoff, E.H., Pyzik, P.L., Ye, X., and Goodman, S.N. (2009). A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 50, 322-325.
53. Freeman, J.M., Vining, E.P., Pillas, D.J., Pyzik, P.L., Casey, J.C., and Kelly, L.M. (1998). The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102, 1358-1363.
54. Frenguelli, B.G., Wigmore, G., Llaudet, E., and Dale, N. (2007). Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J Neurochem 101, 1400-1413.
55. Garre, J.M., Retamal, M.A., Cassina, P., Barbeito, L., Bukauskas, F.F., Saez, J.C., Bennett, M.V., and Abudara, V. (2010). FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc Natl Acad Sci U S A 107, 22659-22664.
56. Gebicke-Haerter, P.J., Christoffel, F., Timmer, J., Northoff, H., Berger, M., and Van Calker, D. (1996). Both adenosine A1-and A2-receptors are required to stimulate microglial proliferation. Neurochem Int 29, 37-42.
57. Geyelin, H.R. (1921). Fasting as a method fo treating epilepsy. Med Rec 99, 1037-1039.
58. Goll, M.G., and Bestor, T.H. (2005). Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74, 481-514.
59. Gomez-Gonzalo, M., Losi, G., Chiavegato, A., Zonta, M., Cammarota, M., Brondi, M., Vetri, F., Uva, L., Pozzan, T., De Curtis, M., Ratto, G.M., and Carmignoto, G. (2010). An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. PLoS Biol 8, e1000352.
60. Gouder, N., Scheurer, L., Fritschy, J.-M., and Boison, D. (2004). Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 24, 692-701.
61. Grabenstatter, H.L., Russek, S.J., and Brooks-Kayal, A.R. (2012). Molecular pathways controlling inhibitory receptor expression. Epilepsia 53 Suppl 9, 71-78.
62. Gray, J.H., Owen, R.P., and Giacomini, K.M. (2004). The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447, 728-734.
63. Guillen-Gomez, E., Calbet, M., Casado, J., De Lecea, L., Soriano, E., Pastor-Anglada, M., and Burgaya, F. (2004). Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep-deprived rats. J Neurochem 90, 883-893.
64. Gupta, A., Ho, D.Y., Brooke, S., Franklin, L., Roy, M., Mclaughlin, J., Fink, S.L., and Sapolsky, R.M. (2001). Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events. Brain Res 908, 49-57.
65. Haberle, J., Shahbeck, N., Ibrahim, K., Hoffmann, G.F., and Ben-Omran, T. (2011). Natural course of glutamine synthetase deficiency in a 3 year old patient. Mol Genet Metab 103, 89-91.
66. Haj-Yasein, N.N., Jensen, V., Vindedal, G.F., Gundersen, G.A., Klungland, A., Ottersen, O.P., Hvalby, O., and Nagelhus, E.A. (2011). Evidence that compromised K+ spatial buffering contributes to the epileptogenic effect of mutations in the human Kir4.1 gene (KCNJ10). Glia 59, 1635-1642.
67. Hasko, G., Linden, J., Cronstein, B., and Pacher, P. (2008). Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7, 759-770.
68. Hasko, G., Pacher, P., Vizi, E.S., and Illes, P. (2005). Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26, 511-516.
69. Hassan, A.M., Keene, D.L., Whiting, S.E., Jacob, P.J., Champagne, J.R., and Humphreys, P. (1999). Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr Neurol 21, 548-552.
70. Heinemann, U., Gabriel, S., Jauch, R., Schulze, K., Kivi, A., Eilers, A., Kovacs, R., and Lehmann, T.N. (2000). Alterations of glial cell function in temporal lobe epilepsy. Epilepsia 41 Suppl 6, S185-189.
71. Heinemann, U., Kaufer, D., and Friedman, A. (2012). Blood-brain barrier dysfunction, TGF-beta signaling and astrocyte dysfunction in epilepsy. Glia in press.
72. Hindley, S., Herman, M.A., and Rathbone, M.P. (1994). Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J Neurosci Res 38, 399-406.
73. Hsu, M.S., Seldin, M., Lee, D.J., Seifert, G., Steinhauser, C., and Binder, D.K. (2011). Laminarspecific and developmental expression of aquaporin-4 in the mouse hippocampus. Neuroscience 178, 21-32.
74. Ivens, S., Kaufer, D., Flores, L.P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., and Friedman, A. (2007). TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130, 535-547.
75. Jen, J.C., Wan, J., Palos, T.P., Howard, B.D., and Baloh, R.W. (2005). Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65, 529-534.
76. Kallioinen, M.J., Heikkinen, E.R., and Nystrom, S. (1987). Histopathological and immunohistochemical changes in neurosurgically resected epileptic foci. Acta Neurochir (Wien) 89, 122-129.
77. Kang, J., Kang, N., Lovatt, D., Torres, A., Zhao, Z., Lin, J., and Nedergaard, M. (2008). Connexin 43 hemichannels are permeable to ATP. J Neurosci 28, 4702-4711.
78. Kawamura, M., Jr., Ruskin, D.N., and Masino, S.A. (2010). Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J Neurosci 30, 3886-3895.
79. Kim, J.H., Roberts, D.S., Hu, Y., Lau, G.C., Brooks-Kayal, A.R., Farb, D.H., and Russek, S.J. (2012). Brain-derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neurons. J Neurochem 120, 210-219.
80. Kinsman, S.L., Vining, E.P., Quaskey, S.A., Mellits, D., and Freeman, J.M. (1992). Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 33, 1132-1136.
81. Kobow, K., and Blumcke, I. (2011). The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia 52 Suppl 4, 15-19.
82. Kobow, K., and Blumcke, I. (2012). The emerging role of DNA methylation in epileptogenesis. Epilepsia 53 Suppl 9, 11-20.
83. Kobow, K., Jeske, I., Hildebrandt, M., Hauke, J., Hahnen, E., Buslei, R., Buchfelder, M., Weigel, D., Stefan, H., Kasper, B., Pauli, E., and Blumcke, I. (2009). Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 68, 356-364.
84. Kofler, J., and Wiley, C.A. (2011). Microglia: key innate immune cells of the brain. Toxicol Pathol 39, 103-114.
85. Kovacs, R., Heinemann, U., and Steinhauser, C. (2012). Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia. Epilepsia 53 Suppl 6, 53-59.
86. Kunz, W.S. (2002). The role of mitochondria in epileptogenesis. Curr Opin Neurol 15, 179-184.
87. Kurzwelly, D., Herrlinger, U., and Simon, M. (2010). Seizures in patients with low-grade gliomas--incidence, pathogenesis, surgical management, and pharmacotherapy. Adv Tech Stand Neurosurg 35, 81-111.
88. Lado, F.A., and Moshe, S.L. (2008). How do seizures stop? Epilepsia 49, 1651-1664.
89. Lahav, N. (1993). The RNA-world and co-evolution hypotheses and the origin of life: implications, research strategies and perspectives. Orig Life Evol Biosph 23, 329-344.
90. Latini, S., and Pedata, F. (2001). Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79, 463-484.
91. Li, T., Ren, G., Lusardi, T., Wilz, A., Lan, J.Q., Iwasato, T., Itohara, S., Simon, R.P., and Boison, D. (2008). Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Inv 118, 571-582; PMCID: PMC2157568
92. Lloyd, H.G., Lindstrom, K., and Fredholm, B.B. (1993). Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int 23, 173-185.
93. Loscher, W., and Brandt, C. (2010). Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62, 668-700.
94. Lovatt, D., Xu, Q., Liu, W., Takano, T., Smith, N.A., Schnermann, J., Tieu, K., and Nedergaard, M. (2012). Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci U S A 109, 6265-6270.
95. Lu, S.C. (2000). S-Adenosylmethionine. Int J Biochem Cell Biol 32, 391-395.
96. Lund, I.V., Hu, Y., Raol, Y.H., Benham, R.S., Faris, R., Russek, S.J., and Brooks-Kayal, A.R. (2008). BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway. Sci Signal 1, ra9.
97. Malik, A., and Buck, L.T. (2010). Adenosinergic modulation of neuronal activity in the pond snail Lymnaea stagnalis. J Exp Biol 213, 1126-1132.
98. Malmgren, K., and Thom, M. (2012). Hippocampal sclerosis--origins and imaging. Epilepsia 53 Suppl 4, 19-33.
99. Marchi, N., Angelov, L., Masaryk, T., Fazio, V., Granata, T., Hernandez, N., Hallene, K., Diglaw, T., Franic, L., Najm, I., and Janigro, D. (2007). Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48, 732-742.
100. Maroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A.M., Rossetti, C., Molteni, M., Casalgrandi, M., Manfredi, A.A., Bianchi, M.E., and Vezzani, A. (2010). Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16, 413-419.
101. Masino, S.A., Li, T., Theofilas, P., Sandau, U.S., Ruskin, D.N., Fredholm, B.B., Geiger, J.D., Aronica, E., and Boison, D. (2011). A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Inv 121, 2679-2683.
102. Mcquarrie, I., and Keith, H.M. (1927). Epilepsy in children: relationship of variations in the defree of ketonuria to occurrence of convulsions in epileptic children on ketogenic diets. Am J Dis Child 34, 1013-1029.
103. Meshorer, E., Biton, I.E., Ben-Shaul, Y., Ben-Ari, S., Assaf, Y., Soreq, H., and Cohen, Y. (2005). Chronic cholinergic imbalances promote brain diffusion and transport abnormalities. Faseb J 19, 910-922.
104. Miyata, H., Hori, T., and Vinters, H.V. (2013). Surgical pathology of epilepsy-associated nonneoplastic cerebral lesions: A brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia. Neuropathology.
105. Nagelhus, E.A., Mathiisen, T.M., and Ottersen, O.P. (2004). Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 129, 905-913.
106. Neal, E.G., Chaffe, H., Schwartz, R.H., Lawson, M.S., Edwards, N., Fitzsimmons, G., Whitney, A., and Cross, J.H. (2008). The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 7, 500-506.
107. Newby, A.C. (1984). Adenosine and the concept of 'retaliatory metabolites'. Trends Biochem Sci 9, 42-44.
108. Newby, A.C., Worku, Y., and Holmquist, C.A. (1985). Adenosine formation. Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol 6, 273-284.
109. Nielsen, S., Nagelhus, E.A., Amiry-Moghaddam, M., Bourque, C., Agre, P., and Ottersen, O.P. (1997). Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 17, 171-180.
110. Oro, J., and Kimball, A.P. (1961). Synthesis of purines under possible primitive earth conditions. I. Adenine from hydrogen cyanide. Arch Biochem Biophys 94, 217-227.
111. Papetti, L., Parisi, P., Leuzzi, V., Nardecchia, F., Nicita, F., Ursitti, F., Marra, F., Paolino, M.C., and Spalice, A. (2012). Metabolic epilepsy: An update. Brain Dev.
112. Pascual, O., Casper, K.B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.Y., Takano, H., Moss, S.J., Mccarthy, K., and Haydon, P.G. (2005). Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113-116.
113. Pazzagli, M., Corsi, C., Fratti, S., Pedata, F., and Pepeu, G. (1995). Regulation of extracellular adenosine levels in the striatum of aging rats. Brain Res 684, 103-106.
114. Peng, L., Huang, R., Yu, A.C., Fung, K.Y., Rathbone, M.P., and Hertz, L. (2005). Nucleoside transporter expression and function in cultured mouse astrocytes. Glia 52, 25-35.
115. Petersen, A.M., Gleeson, T.T., and Scholnick, D.A. (2003). The effect of oxygen and adenosine on lizard thermoregulation. Physiol Biochem Zool 76, 339-347.
116. Petzold, G.C., and Murthy, V.N. (2011). Role of astrocytes in neurovascular coupling. Neuron 71, 782-797.
117. Pignataro, G., Maysami, S., Studer, F.E., Wilz, A., Simon, R.P., and Boison, D. (2008). Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J Cereb Blood Flow Metab 28, 17-23.
118. Raatikainen, M.J., Peuhkurinen, K.J., Kiviluoma, K.T., Hiltunen, J.K., and Hassinen, I.E. (1992). 5'-Nucleotidase activity and adenosine production in rat liver mitochondria. Biochim Biophys Acta 1099, 238-246.
119. Rajagopal, R., Chen, Z.Y., Lee, F.S., and Chao, M.V. (2004). Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24, 6650-6658.
120. Rash, J.E., Yasumura, T., Hudson, C.S., Agre, P., and Nielsen, S. (1998). Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci U S A 95, 11981-11986.
121. Ravizza, T., Balosso, S., and Vezzani, A. (2011). Inflammation and prevention of epileptogenesis. Neurosci Lett 497, 223-230.
122. Ravizza, T., Gagliardi, B., Noe, F., Boer, K., Aronica, E., and Vezzani, A. (2008). Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29, 142-160.
123. Rezin, G.T., Amboni, G., Zugno, A.I., Quevedo, J., and Streck, E.L. (2009). Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34, 1021-1029.
124. Roberts, D.S., Hu, Y., Lund, I.V., Brooks-Kayal, A.R., and Russek, S.J. (2006). Brain-derived neurotrophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons. J Biol Chem 281, 29431-29435.
125. Robertson, M.P., and Joyce, G.F. (2012). The origins of the RNA world. Cold Spring Harb Perspect Biol 4.
126. Rossi, D., and Volterra, A. (2009). Astrocytic dysfunction: Insights on the role in neurodegeneration. Brain Res Bull.
127. Santello, M., Cali, C., and Bezzi, P. (2012). Gliotransmission and the tripartite synapse. Adv Exp Med Biol 970, 307-331.
128. Sarac, S., Afzal, S., Broholm, H., Madsen, F.F., Ploug, T., and Laursen, H. (2009). Excitatory amino acid transporters EAAT-1 and EAAT-2 in temporal lobe and hippocampus in intractable temporal lobe epilepsy. Apmis 117, 291-301.
129. Sas, K., Robotka, H., Toldi, J., and Vecsei, L. (2007). Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257, 221-239.
130. Saura, J., Angulo, E., Ejarque, A., Casado, V., Tusell, J.M., Moratalla, R., Chen, J.F., Schwarzschild, M.A., Lluis, C., Franco, R., and Serratosa, J. (2005). Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem 95, 919-929.
131. Sazanov, A., Atkinson, M.R., Buitkamp, J., and Fries, R. (2000). Chromosomal mapping of adenosine receptor genes in chicken suggests clustering of two members of the gene family. Chromosome Res 8, 173-176.
132. Schwartzkroin, P.A., Baraban, S.C., and Hochman, D.W. (1998). Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res 32, 275-285.
133. Shen, H.Y., Singer, P., Lytle, N., Wei, C.J., Lan, J.Q., Williams-Karnesky, R.L., Chen, J.F., Yee, B.K., and Boison, D. (2012). Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. J Clin Invest 122, 2567-2577.
134. Shepel, P.N., Ramonet, D., Stevens, P., and Geiger, J.D. (2005). Purine level regulation during energy depletion associated with graded excitatory stimulation in brain. Neurological Research 27, 139-148.
135. Sommerschild, H.T., and Kirkeboen, K.A. (2000). Adenosine and cardioprotection during ischaemia and reperfusion--an overview. Acta Anaesthesiol Scand 44, 1038-1055.
136. Sosunov, A.A., Wu, X., Weiner, H.L., Mikell, C.B., Goodman, R.R., Crino, P.D., and Mckhann, G.M., 2nd (2008). Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia 49 Suppl 2, 53-62.
137. Szybala, C., Pritchard, E.M., Wilz, A., Kaplan, D.L., and Boison, D. (2009). Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol 219, 126-135.
138. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., Okuyama, S., Kawashima, N., Hori, S., Takimoto, M., and Wada, K. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699-1702.
139. Tessler, S., Danbolt, N.C., Faull, R.L., Storm-Mathisen, J., and Emson, P.C. (1999). Expression of the glutamate transporters in human temporal lobe epilepsy. Neuroscience 88, 1083-1091.
140. Tian, G.F., Azmi, H., Takano, T., Xu, Q.W., Peng, W.G., Lin, J., Oberheim, N., Lou, N.H., Wang, X.H., Zielke, H.R., Kang, J., and Nedergaard, M. (2005). An astrocytic basis of epilepsy. Nature Medicine 11, 973-981.
141. Tomkins, O., Shelef, I., Kaizerman, I., Eliushin, A., Afawi, Z., Misk, A., Gidon, M., Cohen, A., Zumsteg, D., and Friedman, A. (2008). Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 79, 774-777.
142. Vezzani, A., French, J., Bartfai, T., and Baram, T.Z. (2011a). The role of inflammation in epilepsy. Nat Rev Neurol 7, 31-40.
143. Vezzani, A., Maroso, M., Balosso, S., Sanchez, M.A., and Bartfai, T. (2011b). IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25, 1281-1289.
144. Vining, E.P., Freeman, J.M., Ballaban-Gil, K., Camfield, C.S., Camfield, P.R., Holmes, G.L., Shinnar, S., Shuman, R., Trevathan, E., and Wheless, J.W. (1998). A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 55, 1433-1437.
145. Wang, Y., Zaveri, H.P., Lee, T.S., and Eid, T. (2009). The development of recurrent seizures after continuous intrahippocampal infusion of methionine sulfoximine in rats: a videointracranial electroencephalographic study. Exp Neurol 220, 293-302.
146. Watanabe, T., Morimoto, K., Hirao, T., Suwaki, H., Watase, K., and Tanaka, K. (1999). Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res 845, 92-96.
147. Wilder, R.M. (1921). The effects of ketonemia on the course of epilepsy. Mayo Clin Bull 2, 307-307.
148. Wilder, R.M., and Winter, M.D. (1922). The threshold of ketogenesis. J Biol Chem 52, 393-401.
149. Williams-Karnesky, R.L., Sandau, U.S., Lusardi, T.A., Lytle, N.K., Farrell, J.M., Pritchard, E.M., Kaplan, D.L., and Boison, D. (2013). Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Inv in press.
150. Wong, M., Ess, K.C., Uhlmann, E.J., Jansen, L.A., Li, W., Crino, P.B., Mennerick, S., Yamada, K.A., and Gutmann, D.H. (2003). Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54, 251-256.
151. Zampieri, M., Guastafierro, T., Calabrese, R., Ciccarone, F., Bacalini, M.G., Reale, A., Perilli, M., Passananti, C., and Caiafa, P. (2012). ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites. Biochem J 441, 645-652.
152. Zhang, J.M., Wang, H.K., Ye, C.Q., Ge, W., Chen, Y., Jiang, Z.L., Wu, C.P., Poo, M.M., and Duan, S. (2003). ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40, 971-982.
153. Zhu, Q., Wang, L., Zhang, Y., Zhao, F.H., Luo, J., Xiao, Z., Chen, G.J., and Wang, X.F. (2012). Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 46, 420-426.
154. Zimmermann, H. (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362, 299-309.